INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
1. Pomerantz LLP investigates Mereo for potential securities fraud claims. 2. Mereo's Phase 3 study announcement led to a significant stock price drop. 3. ADR price fell 42.52% to $1.69 following negative news. 4. The investigation could harm investor confidence and brand reputation.